{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:58:46Z","timestamp":1778216326763,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The option B<jats:sup>+<\/jats:sup> prevention of mother to child transmission of human immunodeficiency virus is the lifelong provision of antiretroviral therapy for all human immunodeficiency virus positive pregnant and breastfeeding women regardless of immune status. In Ethiopia, the overall mother-to-child transmission rate of human immunodeficiency virus was 15.9%. This study assessed determinants of human immunodeficiency virus infection among infants born to human immunodeficiency virus positive women on option B\u2009+\u2009prevention of mother to child transmission of human immunodeficiency virus in Tigray, north Ethiopia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Unmatched case-control study was conducted in Tigray region from October 2023 to April 2024. A total of 43 cases and 129 controls were selected using simple random sampling technique. Multivariable logistic regression analysis was fitted to identify the factors associated with mother to child transmission of human immunodeficiency virus at <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05. Multicolinearity was checked among predictor variables using Variance Inflation Factor and Tolerance test. Furthermore, the goodness of fit of the logistic model was tested using Hosmer-Lemshow test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This study showed that rural residence (Adjusted Odds ratio: 33.3, 95% CI: 1.02\u201387.05), World Health Organization disease stage III (Adjusted Odds ratio: 57.4, CI: 9.25\u2013 297.54) and IV (Adjusted Odds ratio: 78.9, CI: 12.64\u2013345.62) during initiation of antiretroviral therapy and a child with mouth ulcer during exclusive breastfeeding (Adjusted Odds ratio: 65, IC: 6.39\u2013456.23) were the factors significantly associated with mother to child transmission of human immunodeficiency virus. Besides, mothers\u2019 educational status (Adjusted Odds ratio: 0.2, CI: 0.04, 0.35), late time of antiretroviral therapy initiation after human immunodeficiency virus diagnosis (Adjusted Odds ratio: 0.14, CI: 0.02\u20130.18) and absence of human immunodeficiency virus exposed infant follow up visit (Adjusted Odds ratio: 0.04, IC: 0.005\u20130.09) had significant association with the mother to child transmission of human immunodeficiency virus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The determinant factors significantly associated with mother to child transmission of human immunodeficiency virus were identified. Health care providers should strengthen option B\u2009+\u2009prevention mother to child transmission of human immunodeficiency virus services to reduce the mother to child transmission of human immunodeficiency virus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12981-025-00755-3","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T12:32:42Z","timestamp":1748608362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determinants of HIV infection among infants born to HIV positive women receiving option B\u2009+\u2009prevention of mother to child transmission of HIV in Tigray, north Ethiopia: a case control study"],"prefix":"10.1186","volume":"22","author":[{"given":"Haftay","family":"Gebremedhin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fre","family":"Gebremeskel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gebremedhin","family":"Gebreegziabiher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abadi Hailay","family":"Atsbaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gebretekle Gebremichael","family":"Hailesilase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"755_CR1","unstructured":"Darby B, Jones A, Hope S, Hiv K. World Health Organization guidelines (Option A, B, and B+) for antiretroviral drugs to treat pregnant women and prevent HIV infection in infants. The Embryo Project Encyclopedia. Tempe; The Embryo Project at Arizona State University; 2021. pp. 1\u20137."},{"issue":"39","key":"755_CR2","first-page":"1","volume":"21","author":"W Facha","year":"2024","unstructured":"Facha W, Tadesse T, Wolka E, Astatkie A. Magnitude and risk factors of mother-to- child transmission of HIV among HIV-exposed infants after option B\u2009+\u2009implementation in Ethiopia: a systematic review and meta- analysis. AIDS Res Ther. 2024;21(39):1\u201312.","journal-title":"AIDS Res Ther"},{"key":"755_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijid.2020.03.006","volume":"95","author":"A Mamo","year":"2020","unstructured":"Mamo A, Beletew B. International journal of infectious diseases Mother-to-child HIV transmission and its associations among exposed infants after option B\u2009+\u2009guidelines implementation in the Amhara regional state referral hospitals, Ethiopia. Int J Infect Dis. 2020;95:268\u201375.","journal-title":"Int J Infect Dis"},{"key":"755_CR4","unstructured":"World Health Organization (WHO). PMTCT strategic vision 2010\u20132015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals: moving towards the elimination of paediatric HIV; Geneva, World Health Organization [Internet]. 2010. Available from: https:\/\/iris.who.int\/handle\/10665\/44268 [Accessed 10 March 2024]."},{"key":"755_CR5","unstructured":"United Nations AIDS (UNAIDS). Joint United Nations Programme on HIV\/AIDS; Appia, Geneva, Switzerland: Global AIDS Update. 2016. pp. 1\u201316."},{"key":"755_CR6","unstructured":"United Nations. Conferences on HIV\/AIDS: 26th Special Session of the General Assembly on HIV \/ AIDS; New York. 2011."},{"key":"755_CR7","first-page":"1","volume":"6","author":"E Israel","year":"2024","unstructured":"Israel E, Astatkie A, Taye K, Christou A, Lejore E, Asefa A. Determinants of HIV infection at 18 months of age among HIV-exposed infants in the context of PMTCT interventions. Fronfiers Reprod Heal. 2024;6:1\u20139.","journal-title":"Fronfiers Reprod Heal"},{"key":"755_CR8","volume-title":"Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis,2nd edition","author":"World Health Organization (WHO)","year":"2017","unstructured":"World Health Organization (WHO). Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis,2nd edition. Geneva: World Health Organization; 2017."},{"key":"755_CR9","unstructured":"World Health Organization Departments of Child and Adolescent Health and, Development. and HIV, in collaboration with UNAIDS U and U. Guidelines on HIV and infant feeding: principles and recommendations for infant feeding in the context of HIV and a summary of evidence. 2010. 1\u201349 p."},{"key":"755_CR10","unstructured":"Wolrd Health organization(WHO). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV; Geneva, World Health Organization. 2015."},{"key":"755_CR11","unstructured":"United Nations Children\u2019s Fund (UNICEF). Evaluation of united nations-supported pilot projects for the mother-to-child transmission of HIV: overview of findings. 2003. 1\u201347 p."},{"key":"755_CR12","unstructured":"World Health Organization (WHO). Global Health Observatory (GHO) data repository: Births attended by skilled health personnel. 2024."},{"key":"755_CR13","unstructured":"United Nations AIDS (UNAIDS). President\u2019s Emergency Plan for AIDS Relief (PEPFAR) and Partners \u2018Start Free, Stay Free, AIDS Free: A super-fast track framework for ending AIDS among children, adolescents and young women by 2020. In 2020."},{"key":"755_CR14","unstructured":"United Nations AIDS(UNAIDS). Start Free Stay Free AIDS Free: 2017 progress report. 2017."},{"key":"755_CR15","doi-asserted-by":"crossref","unstructured":"Marinda ET, Moulton LH, Humphrey JH, Hargrove JW, Ntozini R, Mutasa K et al. In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infection. Int J Epidemiol. 2011;40945\u2013954. 2011;40(4):945\u201354.","DOI":"10.1093\/ije\/dyr055"},{"key":"755_CR16","unstructured":"World Health Organisation (WHO). Global HIV Programme: Mother-to-child transmission of HIV Globally. 2014."},{"key":"755_CR17","unstructured":"Central statistical agency (CSA). Population Projections for Ethiopia: Ethiopian Demographic and Health survey; Addis Ababa, CSA. 2013."},{"key":"755_CR18","unstructured":"Burusie A, Deyessa N. Determinants of Mother-To-Child HIV transmission methods. Cell Dev Biol. 2015;4(152)."},{"key":"755_CR19","unstructured":"Ethiopian Minisrty of Ethiopia. Prevention of Mother to Child Transmission (PMTCT). 2024. p. 517011."},{"issue":"29","key":"755_CR20","first-page":"1","volume":"13","author":"T Olana","year":"2016","unstructured":"Olana T, Bacha T, Worku W, Tadesse BT. Early infant diagnosis of HIV infection using DNA\u2013 PCR at a referral center: an 8 years retrospective analysis. AIDS Res Ther. 2016;13(29):1\u20137.","journal-title":"AIDS Res Ther"},{"issue":"327","key":"755_CR21","first-page":"1","volume":"18","author":"GA Beyene","year":"2018","unstructured":"Beyene GA, Dadi LS, Mogas SB. Determinants of HIV infection among children born to mothers on prevention of mother to child transmission program of HIV in addis Ababa, Ethiopia: a case control study. BMC Infect Dis. 2018;18(327):1\u201310.","journal-title":"BMC Infect Dis"},{"key":"755_CR22","unstructured":"Bureau Tigray Region Health. Tigray Region Health Bureau Tigray profile for the 20011\/12 Ethiopian Fiscal Year. 2024. p. 517011."},{"issue":"1","key":"755_CR23","first-page":"1","volume":"13","author":"DN Koye","year":"2013","unstructured":"Koye DN, Zeleke BM. Mother-to-child transmission of HIV and its predictors among HIV-exposed infants at a PMTCT clinic in Northwest Ethiopia. BMC Public Heal 2013. 2013;13(1):1\u20136.","journal-title":"BMC Public Heal 2013"},{"issue":"1","key":"755_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4236\/ijcm.2014.58065","volume":"5","author":"Z Berhan","year":"2014","unstructured":"Berhan Z, Abebe F, Gedefaw M, Tesfa M. Prevalence of HIV and associated factors among infants born to HIV positive women in Amhara region, Ethiopia. Int J Clin Med. 2014;5(1):464\u201374.","journal-title":"Int J Clin Med"},{"issue":"163","key":"755_CR25","first-page":"1","volume":"8","author":"ND Amaha","year":"2019","unstructured":"Amaha ND, Weldemariam DG, Abdu N, Tesfamariam EH. Prescribing practices using WHO prescribing indicators and factors associated with antibiotic prescribing in six community pharmacies in Asmara, Eritrea: a cross-sectional study. Antimicrob Resist Infect Control. 2019;8(163):1\u20137.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"755_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-6113.1000605","volume":"7","author":"B Birlie","year":"2016","unstructured":"Birlie B, Diriba TA, Sisay K, Gurmessa A, Seyoum D, Tadesse M. AIDS & clinical research mother to child HIV transmission and its predictors among HIV-Exposed infants: A retrospective Follow-Up study in Southwest Ethiopia. J AIDS Clin Res. 2016;7(9):1\u20137.","journal-title":"J AIDS Clin Res"},{"issue":"309","key":"755_CR27","first-page":"1","volume":"7","author":"G Derebe","year":"2014","unstructured":"Derebe G, Biadgilign S, Trivelli M, Hundessa G, Robi ZD, Gebre-mariam M, et al. Determinant and outcome of early diagnosis of HIV infection among HIV-exposed infants in Southwest Ethiopia. BMC Res Notes 2014. 2014;7(309):1\u20138.","journal-title":"BMC Res Notes 2014"},{"issue":"876","key":"755_CR28","first-page":"1","volume":"7","author":"Z Berhan","year":"2014","unstructured":"Berhan Z, Abebe F, Gedefaw M, Tesfa M, Assefa M, Tafere Y. Risk of HIV and associated factors among infants born to HIV positive women in Amhara region, Ethiopia: a facility based retrospective study. BMC Res Notes. 2014;7(876):1\u20139.","journal-title":"BMC Res Notes"},{"key":"755_CR29","doi-asserted-by":"crossref","unstructured":"Abajobir AA, Zeleke AB, Knowledge. Attitude, practice and factors associated with prevention of Mother-to-Child transmission of HIV \/ AIDS among pregnant mothers attending antenatal clinic in Hawassa referral hospital, South Ethiopia AIDS & clinical research. J AIDS Clin Res Abajobir. 2013;4(6).","DOI":"10.4172\/2155-6113.1000215"},{"issue":"1","key":"755_CR30","first-page":"1","volume":"19","author":"I Mitiku","year":"2016","unstructured":"Mitiku I, Arefayne M, Mesfin Y, Gizaw M. Factors associated with loss to follow-up among women in option B \u2019 PMTCT programme in Northeast Ethiopia: a retrospective cohort study. J Int AIDS Soc 2016. 2016;19(1):1\u20138.","journal-title":"J Int AIDS Soc 2016"},{"issue":"Suppl 2","key":"755_CR31","first-page":"1","volume":"15","author":"MH Kim","year":"2012","unstructured":"Kim MH, Ahmed S, Buck WC, Preidis GA, Hosseinipour MC, Bhalakia A, et al. The tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi. J Int AIDS Soc. 2012;15(Suppl 2):1\u201311.","journal-title":"J Int AIDS Soc"},{"issue":"24","key":"755_CR32","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","volume":"362","author":"RL Shapiro","year":"2010","unstructured":"Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, et al. Antiretroviral regimens in pregnancy and Breast-Feeding in Botswana. N Engl J Med. 2010;362(24):2282\u201394.","journal-title":"N Engl J Med"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00755-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T12:32:48Z","timestamp":1748608368000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00755-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00755-3","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adigrat University\u2019s institutional review board approved the study and a formal letter of permission was obtained from Adigrat University. An official letter of cooperation from the above organization was written to the respective health facilities. There was no potential risk that might cause any harm to respondents. The importance of the study was explained to the participants of the study and informed oral consent was requested from the study participants immediately before the data collection. All respondents were informed of the right to withdraw or refuse to participate in this study at any time. The privacy and confidentiality of respondents were ensured by using a unique code.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}